Literature DB >> 9867251

Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.

N Douziech1, A Lajas, Z Coulombe, E Calvo, J Lainé, J Morisset.   

Abstract

The intracellular events involved in normal pancreatic growth have been extensively investigated in response to cholecystokinin. Recent data indicate that tyrosine kinase, phospholipase D, phosphatidylinositol 3-kinase, and p42/p44 MAPK are stimulated in rat pancreatic acinar cells. Although we begin to understand the intracellular signaling pathways activated in normal pancreas, such information is not yet available in pancreatic cancer cells. This study was undertaken to identify the growth factors and hormones involved in cell proliferation of two human pancreatic cancer cell lines of ductal origin, the MIA PaCa-2, and PANC-1 cells, and to establish the intracellular events involved in the control of their growth. We demonstrated that FGF-2, IGF-1, cerulein, and gastrin but not FGF-1, HGF, secretin, and PACAP, stimulated proliferation of MIA PaCa-2 and PANC-1 cells. Autocrine factors such as gastrin and IGF-1 were also responsible for their proliferation. In response to EGF, FGF-2, IGF-1, cerulein, gastrin and bombesin, tyrosine kinase, and tyrosine phosphatase activities were stimulated in both cell lines. The close relationship established between cell growth and tyrosine kinase activation results from the observation that maximal growth stimulation paralleled with maximal enzyme activation and that genistein, the tyrosine kinase inhibitor, blocked cell growth and enzyme activation. The implication of PLD in growth-stimulated processes is doubtful since all growth factors and hormones tested failed to stimulate an already very active PLD activity. We finally observed a constitutive activity of p44 MAPK in both cell lines and of p42 in MIA PaCa-2 cells. However, p38 and p42 were stimulated in MIA PaCa-2 and PANC-1 cells, respectively, by all growth factors and hormones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867251     DOI: 10.1385/ENDO:9:2:171

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  50 in total

1.  CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium.

Authors:  J P Smith; S T Kramer; T E Solomon
Journal:  Regul Pept       Date:  1991-02-26

2.  Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal.

Authors:  K Fukami; T Takenawa
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

3.  SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase.

Authors:  Z Yu; L Su; O Hoglinger; M L Jaramillo; D Banville; S H Shen
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

4.  Proceedings: The trophic influence of cholecystokinin on the rat pancreas.

Authors:  J A Barrowman; P D Mayston
Journal:  J Physiol       Date:  1974-04       Impact factor: 5.182

5.  Cell site and time course of DNA synthesis in pancreas after caerulein and secretin.

Authors:  T E Solomon; M Vanier; J Morisset
Journal:  Am J Physiol       Date:  1983-07

6.  Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.

Authors:  R M Liehr; G Melnykovych; T E Solomon
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

7.  Involvement of Ral GTPase in v-Src-induced phospholipase D activation.

Authors:  H Jiang; J Q Luo; T Urano; P Frankel; Z Lu; D A Foster; L A Feig
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

8.  Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini.

Authors:  R D Duan; C F Zheng; K L Guan; J A Williams
Journal:  Am J Physiol       Date:  1995-06

9.  Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide.

Authors:  L Buscail; C Cambillau; C Seva; J L Scemama; P De Neef; P Robberecht; J Christophe; C Susini; N Vaysse
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

Review 10.  The base exchange enzymes and phospholipase D of mammalian tissue.

Authors:  J N Kanfer
Journal:  Can J Biochem       Date:  1980-12
View more
  3 in total

1.  Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.

Authors:  Meike Körner; Gregory M Hayes; Ruth Rehmann; Arthur Zimmermann; Helmut Friess; Laurence J Miller; Jean Claude Reubi
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 2.  Genetically engineered mouse models of pancreatic adenocarcinoma.

Authors:  Carmen Guerra; Mariano Barbacid
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

Review 3.  Targeting phospholipase D in cancer, infection and neurodegenerative disorders.

Authors:  H Alex Brown; Paul G Thomas; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.